Related references
Note: Only part of the references are listed.Levoketoconazole, the 2S,4R Enantiomer of Ketoconazole, a New Steroidogenesis Inhibitor for Cushing's Syndrome Treatment
Sara G. Creemers et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2021)
Levoketoconazole improves clinical signs and symptoms and patient-reported outcomes in patients with Cushing's syndrome
Eliza B. Geer et al.
PITUITARY (2021)
Updates in adrenal steroidogenesis inhibitors for Cushing's syndrome - A practical guide
Elena V. Varlamov et al.
BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM (2021)
Cardiovascular risk assessment, thromboembolism, and infection prevention in Cushing?s syndrome: a practical approach
Elena V. Varlamov et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2021)
Levoketoconazole in the Treatment of Patients With Cushing's Syndrome and Diabetes Mellitus: Results From the SONICS Phase 3 Study
Rosario Pivonello et al.
FRONTIERS IN ENDOCRINOLOGY (2021)
Adrenally Directed Medical Therapies for Cushing Syndrome
Nicholas A. Tritos
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2021)
Use of late-night salivary cortisol to monitor response to medical treatment in Cushing's disease
John Newell-Price et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2020)
Efficacy and safety of osilodrostat in patients with Cushing's disease (LINC 3): a multicentre phase III study with a double-blind, randomised withdrawal phase
Rosario Pivonello et al.
LANCET DIABETES & ENDOCRINOLOGY (2020)
Advances in the medical treatment of Cushing's syndrome
Richard A. Feelders et al.
LANCET DIABETES & ENDOCRINOLOGY (2019)
Therapeutic options after surgical failure in Cushing's disease: A critical review
German Rubinstein et al.
BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM (2019)
The incidence of endogenous Cushing's syndrome in the modern era
Sofie Wengander et al.
CLINICAL ENDOCRINOLOGY (2019)
Medical Management of Cushing's Syndrome: Current and Emerging Treatments
Jose Miguel Hinojosa-Amaya et al.
DRUGS (2019)
Radiotherapy as a tool for the treatment of Cushing's disease
Frederic Castinetti et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2019)
Effects of Ketoconazole on ACTH-Producing and Non-ACTH-Producing Neuroendocrine Tumor Cells
Aura D. Herrera-Martinez et al.
HORMONES & CANCER (2019)
Efficacy and safety of levoketoconazole in the treatment of endogenous Cushing's syndrome (SONICS): a phase 3, multicentre, open-label, single-arm trial
Maria Fleseriu et al.
LANCET DIABETES & ENDOCRINOLOGY (2019)
Medical Therapy for Cushing's Syndrome in the Twenty-first Century
Nicholas A. Tritos et al.
ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA (2018)
Hepatic safety of ketoconazole in Cushing's syndrome: results of a Compassionate Use Programme in France
Jacques Young et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2018)
Efficacy and safety of once-monthly pasireotide in Cushing's disease: a 12 month clinical trial
Andre Lacroix et al.
LANCET DIABETES & ENDOCRINOLOGY (2018)
Diabetes Mellitus Secondary to Cushing's Disease
Mattia Barbot et al.
FRONTIERS IN ENDOCRINOLOGY (2018)
Multiple salivary cortisol Measurements are a Useful Tool to Optimize Metyrapone Treatment in Patients with cushing's syndromes Treatment: case Presentations
Kenichi Yoshida et al.
FRONTIERS IN ENDOCRINOLOGY (2018)
Transporters Involved in Metformin Pharmacokinetics and Treatment Response
Xiaomin Liang et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2017)
BIOCHEMICAL CONTROL DURING LONG-TERM FOLLOW-UP OF 230 ADULT PATIENTS WITH CUSHING DISEASE: A MULTICENTER RETROSPECTIVE STUDY
Eliza B. Geer et al.
ENDOCRINE PRACTICE (2017)
Psychiatric Symptoms in Patients with Cushing's Syndrome: Prevalence, Diagnosis and Management
Alicia Santos et al.
DRUGS (2017)
Diabetes in Cushing Disease
G. Mazziottil et al.
CURRENT DIABETES REPORTS (2017)
No Untoward Effect of Long-Term Ketoconazole Administration on Electrocardiographic QT Interval in Patients with Cushing's Disease
Martina De Martin et al.
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY (2016)
Osilodrostat, a potent oral 11β-hydroxylase inhibitor: 22-week, prospective, Phase II study in Cushing's disease
Maria Fleseriu et al.
PITUITARY (2016)
Design, synthesis, and evaluation of (2S, 4R)-Ketoconazole sulfonamide analogs as potential treatments for Metabolic Syndrome
Benjamin E. Blass et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2016)
Management of adrenal incidentalomas: European Society of Endocrinology Clinical Practice Guideline in collaboration with the European Network for the Study of Adrenal Tumors
Martin Fassnacht et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2016)
Updates on the role of adrenal steroidogenesis inhibitors in Cushing's syndrome: a focus on novel therapies
Maria Fleseriu et al.
PITUITARY (2016)
Complications of Cushing's syndrome: state of the art
Rosario Pivonello et al.
LANCET DIABETES & ENDOCRINOLOGY (2016)
Mortality in patients with Cushing's disease more than 10 years after remission: a multicentre, multinational, retrospective cohort study
Richard N. Clayton et al.
LANCET DIABETES & ENDOCRINOLOGY (2016)
The Treatment of Cushing's Disease
Rosario Pivonello et al.
ENDOCRINE REVIEWS (2015)
A critical reappraisal of bilateral adrenalectomy for ACTH-dependent Cushing's syndrome
Martin Reincke et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2015)
MANAGEMENT OF ENDOCRINE DISEASE Mortality remains increased in Cushing's disease despite biochemical remission: a systematic review and meta-analysis
Femke M. van Haalen et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2015)
Treatment of Cushing's Syndrome: An Endocrine Society Clinical Practice Guideline
Lynnette K. Nieman et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2015)
Effectiveness of Metyrapone in Treating Cushing's Syndrome: A Retrospective Multicenter Study in 195 Patients
Eleni Daniel et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2015)
Neuropsychiatric disorders in Cushing's syndrome
Rosario Pivonello et al.
FRONTIERS IN NEUROSCIENCE (2015)
Ketoconazole as an Adrenal Steroidogenesis Inhibitor: Effectiveness and Risks in the Treatment of Cushing's Disease
John Newell-Price
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2014)
Changes in Plasma ACTH Levels and Corticotroph Tumor Size in Patients With Cushing's Disease During Long-term Treatment With the Glucocorticoid Receptor Antagonist Mifepristone
Maria Fleseriu et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2014)
Ketoconazole in Cushing's Disease: Is It Worth a Try?
Frederic Castinetti et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2014)
Dual Effects of Ketoconazole cis-Enantiomers on CYP3A4 in Human Hepatocytes and HepG2 Cells
Aneta Novotna et al.
PLOS ONE (2014)
Multisystem Morbidity and Mortality in Cushing's Syndrome: A Cohort Study
Olaf M. Dekkers et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2013)
Pharmacokinetic interaction between domperidone and ketoconazole leads to QT prolongation in healthy volunteers: a randomized, placebo-controlled, double-blind, crossover study
Malcolm J. Boyce et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2012)
Efficiency and tolerance of mitotane in Cushing's disease in 76 patients from a single center
Camille Baudry et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2012)
Cushing Syndrome: Maybe Not So Uncommon of an Endocrine Disease
Federica Guaraldi et al.
JOURNAL OF THE AMERICAN BOARD OF FAMILY MEDICINE (2012)
A 12-Month Phase 3 Study of Pasireotide in Cushing's Disease
Annamaria Colao et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Circadian rhythm of adrenal glucocorticoid: Its regulation and clinical implications
Sooyoung Chung et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2011)
Adrenocorticotrophic hormone (ACTH) responsiveness to ghrelin increases after 6 months of ketoconazole use in patients with Cushing's disease: comparison with GH-releasing peptide-6 (GHRP-6)
Silvia R. Correa-Silva et al.
CLINICAL ENDOCRINOLOGY (2010)
Ketoconazole enantiomer for the treatment of diabetes mellitus
Richard Arakaki et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2010)
Pasireotide Alone or with Cabergoline and Ketoconazole in Cushing's Disease
Richard A. Feelders et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Bile acids: regulation of synthesis
John Y. L. Chiang
JOURNAL OF LIPID RESEARCH (2009)
Coexistence of hERG current block and disruption of protein trafficking in ketoconazole-induced long QT syndrome
H. Takemasa et al.
BRITISH JOURNAL OF PHARMACOLOGY (2008)
Safety profile and metabolic effects of 14 days of treatment with DIO-902: Results of a phase IIa multicenter, randomized, double-blind, placebo-controlled, parallel-group trial in patients with type 2 diabetes mellitus
Sherwyn L. Schwartz et al.
CLINICAL THERAPEUTICS (2008)
Ketoconazole revisited: a preoperative or postoperative treatment in Cushing's disease
F. Castinetti et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2008)
Effect of one month ketoconazole treatment on GH, cortisol and ACTH release after ghrelin, GHRP-6 and GHRH administration in patients with Cushing's disease
Silvia R. Correa-Silva et al.
ARQUIVOS BRASILEIROS DE ENDOCRINOLOGIA E METABOLOGIA (2007)
Enantioselectivity of inhibition of cytochrome P450 3A4 (CYP3A4) by ketoconazole: Testosterone and methadone as substrates
S Dilmaghanian et al.
CHIRALITY (2004)
Share Paper
